Search research articles
Contact Us
Filters
Showing results (31-40 of 78) with videos related to
Page
of 8
Sort By:
Melanoma Research
|
March 1, 1994
Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study
D Liénard, A M Eggermont, H Schraffordt Koops, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1997
Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line
G A Waanders, D Rimoldi, D Liénard, et al.
Ernst Schering Research Foundation Workshop
|
August 16, 2000
Immune monitoring in cancer immunotherapy
P Romero, M J Pittet, D Valmori, et al.
Surgical Oncology Clinics of North America
|
October 20, 2001
Isolated limb perfusion: the European experience
F J Lejeune, B B Kroon, F Di Filippo, et al.
International Immunopharmacology
|
July 20, 2001
Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patients
M J Pittet, D E Speiser, D Valmori, et al.
Journal of the National Cancer Institute
|
August 5, 1999
Sunscreen use and duration of sun exposure: a double-blind, randomized trial
P Autier, J F Doré, S Négrier, et al.
Cancer Research
|
May 8, 1999
An antigen-targeted approach to adoptive transfer therapy of cancer
D Valmori, M J Pittet, D Rimoldi, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
March 24, 1999
Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study
A F Olieman, D Liénard, A M Eggermont, et al.
European Journal of Immunology
|
September 6, 2001
Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing
M Ayyoub, M Migliaccio, P Guillaume, et al.
Cancer Research
|
February 24, 2001
Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma
D Valmori, V Dutoit, V Rubio-Godoy, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 78) with videos related to
Sort By:
Page
of 8
Melanoma Research
|
March 1, 1994
Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study
D Liénard, A M Eggermont, H Schraffordt Koops, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 1, 1997
Melanoma-reactive human cytotoxic T lymphocytes derived from skin biopsies of delayed-type hypersensitivity reactions induced by injection of an autologous melanoma cell line
G A Waanders, D Rimoldi, D Liénard, et al.
Ernst Schering Research Foundation Workshop
|
August 16, 2000
Immune monitoring in cancer immunotherapy
P Romero, M J Pittet, D Valmori, et al.
Surgical Oncology Clinics of North America
|
October 20, 2001
Isolated limb perfusion: the European experience
F J Lejeune, B B Kroon, F Di Filippo, et al.
International Immunopharmacology
|
July 20, 2001
Ex vivo analysis of tumor antigen specific CD8+ T cell responses using MHC/peptide tetramers in cancer patients
M J Pittet, D E Speiser, D Valmori, et al.
Journal of the National Cancer Institute
|
August 5, 1999
Sunscreen use and duration of sun exposure: a double-blind, randomized trial
P Autier, J F Doré, S Négrier, et al.
Cancer Research
|
May 8, 1999
An antigen-targeted approach to adoptive transfer therapy of cancer
D Valmori, M J Pittet, D Rimoldi, et al.
Archives of Surgery (Chicago, Ill. : 1960)
|
March 24, 1999
Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study
A F Olieman, D Liénard, A M Eggermont, et al.
European Journal of Immunology
|
September 6, 2001
Lack of tumor recognition by hTERT peptide 540-548-specific CD8(+) T cells from melanoma patients reveals inefficient antigen processing
M Ayyoub, M Migliaccio, P Guillaume, et al.
Cancer Research
|
February 24, 2001
Frequent cytolytic T-cell responses to peptide MAGE-A10(254-262) in melanoma
D Valmori, V Dutoit, V Rubio-Godoy, et al.
Page
of 8